tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
Company AnnouncementsAgenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
6d ago
AGEN
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
22d ago
QSI
AGEN
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
PremiumRatings
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
27d ago
AGEN
Agenus Announces Resignation of Principal Accounting Officer
PremiumCompany Announcements
Agenus Announces Resignation of Principal Accounting Officer
1M ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
1M ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatingsAgenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
1M ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
Premium
The Fly
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
1M ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
Premium
The Fly
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
1M ago
AGEN
Agenus provides 2026 strategic priorities
PremiumThe Fly
Agenus provides 2026 strategic priorities
1M ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
PremiumThe Fly
Agenus announces conclusion of SEC investigation with no enforcement action
1M ago
AGEN
AGEN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AGEN Earnings this Week: How Will it Perform?
1M ago
AGEN
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
PremiumThe Fly
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
2M ago
AGEN
Agenus reports Phase 2 results from BOT and BAL with agenT-797
PremiumThe FlyAgenus reports Phase 2 results from BOT and BAL with agenT-797
2M ago
AGEN
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
Premium
The Fly
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
3M ago
AGEN
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
Premium
Ratings
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
3M ago
AGEN
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
PremiumCompany Announcements
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
3M ago
AGEN
Agenus Securities Class Action Dismissed, Legal Risks Ease
PremiumCompany Announcements
Agenus Securities Class Action Dismissed, Legal Risks Ease
3M ago
8K
AGEN
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
PremiumRatings
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
3M ago
AGEN
Options Volatility and Implied Earnings Moves Today, March 16, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 16, 2026
3M ago
NIU
AGEN
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
3M ago
M
MU
Agenus Inc. (AGEN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Agenus Inc. (AGEN) Q4 Earnings Cheat Sheet
3M ago
AGEN
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
Premium
The Fly
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
3M ago
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >